Advances in CAR-T therapy for central nervous system lymphoma.

Feng X, Yang J, Xu X, Kai W, Huang Y, Zhang S, Su L, Zhang L.

Open source

DOI: 10.3389/fimmu.2026.1858455
Published: 2026-08-21
Container: Front Immunol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1858455,
  title = {Advances in CAR-T therapy for central nervous system lymphoma.},
  author = {Feng X and  Yang J and  Xu X and  Kai W and  Huang Y and  Zhang S and  Su L and  Zhang L.},
  year = {2026},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2026.1858455},
  url = {https://doi.org/10.3389/fimmu.2026.1858455}
}

RIS

TY  - JOUR
TI  - Advances in CAR-T therapy for central nervous system lymphoma.
AU  - Feng X
AU  -  Yang J
AU  -  Xu X
AU  -  Kai W
AU  -  Huang Y
AU  -  Zhang S
AU  -  Su L
AU  -  Zhang L.
PY  - 2026
JO  - Front Immunol
DO  - 10.3389/fimmu.2026.1858455
UR  - https://doi.org/10.3389/fimmu.2026.1858455
ER  -

APA

X, F., J, Y., X, X., W, K., Y, H., S, Z., L, S., & L., Z. (2026). Advances in CAR-T therapy for central nervous system lymphoma.. Front Immunol. https://doi.org/10.3389/fimmu.2026.1858455

Source records

europe-pmc · retrieved 2026-09-25T09:14:08.241Z
doaj · retrieved 2026-09-25T09:14:08.228Z